AR2I Sa Analyses Recherches Et Innovation Instrumentale
AR2I Sa Analyses Recherches Et Innovation Instrumentale is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A randomized, open-label, phase 3 trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic Non-Small Cell Lung Cancer (NSCLC) and secondary resistance to Immune Checkpoint Inhibitor (ICI) - ARTEMIA study
Sponsor OSE Immunotherapeutics
- Start (EU)
- Latest update
- Estimated end
A multicenter phase 1/2 dose-finding and dose expansion study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas
Sponsor OSE Immunotherapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for AR2I Sa Analyses Recherches Et Innovation Instrumentale?
The 2026-10-09 snapshot links AR2I Sa Analyses Recherches Et Innovation Instrumentale to 2 distinct CTIS trials. Recorded services include IMP Testing, Storage, Testing of IMP. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for AR2I Sa Analyses Recherches Et Innovation Instrumentale?
The most frequently recorded therapeutic areas are Solid Tumor Oncology, Haematological Malignancies. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to AR2I Sa Analyses Recherches Et Innovation Instrumentale conducted?
The linked trials record locations in 11 countries, including Belgium, Spain, France, Germany, Greece. These are trial locations, not confirmed office locations or countries where AR2I Sa Analyses Recherches Et Innovation Instrumentale delivered services.
What can this page tell me about AR2I Sa Analyses Recherches Et Innovation Instrumentale's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under AR2I Sa Analyses Recherches Et Innovation Instrumentale. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- AR2I Sa Analyses Recherches Et Innovation Instrumentale